Department of Medicine, Université de Montréal, Montréal, Québec, Canada H3C 3J7.
J Physiol. 2012 Mar 15;590(6):1313-30. doi: 10.1113/jphysiol.2011.222794. Epub 2011 Dec 19.
G protein-coupled receptors (GPCRs) play key physiological roles in numerous tissues, including the heart, and their dysfunction influences a wide range of cardiovascular diseases. Recently, the notion of nuclear localization and action of GPCRs has become more widely accepted. Nuclear-localized receptors may regulate distinct signalling pathways, suggesting that the biological responses mediated by GPCRs are not solely initiated at the cell surface but may result from the integration of extracellular and intracellular signalling pathways. Many of the observed nuclear effects are not prevented by classical inhibitors that exclusively target cell surface receptors, presumably because of their structures, lipophilic properties, or affinity for nuclear receptors. In this topical review, we discuss specifically how angiotensin-II, endothelin, β-adrenergic and opioid receptors located on the nuclear envelope activate signalling pathways, which convert intracrine stimuli into acute responses such as generation of second messengers and direct genomic effects, and thereby participate in the development of cardiovascular disorders.
G 蛋白偶联受体(GPCRs)在许多组织中发挥着关键的生理作用,包括心脏,其功能障碍会影响广泛的心血管疾病。最近,GPCR 核定位和作用的概念被更广泛地接受。核定位受体可能调节不同的信号通路,表明 GPCR 介导的生物学反应不仅起始于细胞表面,还可能是细胞外和细胞内信号通路整合的结果。许多观察到的核效应不能被专门针对细胞表面受体的经典抑制剂所阻止,这可能是因为它们的结构、亲脂性或与核受体的亲和力。在这篇专题评论中,我们特别讨论了位于核膜上的血管紧张素 II、内皮素、β-肾上腺素能和阿片受体如何激活信号通路,这些信号通路将胞内刺激转化为急性反应,如第二信使的产生和直接的基因组效应,从而参与心血管疾病的发展。